Safety and Pharmacokinetic (PK) Study of Oral Bendavia Administered for 7 Days
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the study medication blood levels after administration
of a repeat oral capsules (one capsule each day for seven days) of Bendavia at one of two
dose levels. The effects of Bendavia on the volunteers will also be assessed.